Clinical outcomes following selective laser trabeculoplasty in Afro-Caribbean patients with glaucoma at high risk for progression
Conclusions
Afro-Caribbean patients with OAG at risk for progression can achieve clinically and statistically significant reductions in IOP or medications through up to 24 months following a single 360° SLT treatment.
Trial registration number
NCT02375009.
Source: British Journal of Ophthalmology - Category: Opthalmology Authors: Realini, T., Shillingford-Ricketts, H., Burt, D., Balasubramani, G. K. Tags: Original articles - Clinical science Source Type: research
More News: Blindness | Eyes | Glaucoma | Laser Trabeculoplasty | Opthalmology | Science | Statistics | UK Health